Related Experiment Video
Updated: Jul 6, 2026

Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
Published on: August 22, 2025
[Use of cannabinoids in palliative medicine]
Gernot Ernst1, Ulf E Kongsgaard
1Smerte- og palliativseksjon, Akuttklinikken, Blefjell Sykehus Kongsberg, 3672 Notodden. gernot.ernst@blefjellsykehus.no
Background:
Several countries use drugs containing cannabinoids for symptom management in patients that need palliative treatment.
Material And Method:
Articles were retrieved through a literature search for randomized controlled studies of cannabinoids used to treat cancer-related symptoms such as pain, nausea and appetite.
Results:
Evidence for clinical effect is limited. Some randomized studies have shown a treatment effect of cannabinoids in neuropathic pain. Cannabinoid-containing drugs can have a moderate anti-emetic effect and can stimulate appetite in some subgroups of patients.
Interpretation:
Many questions about clinical efficacy and side effects have still not been answered for cannabinoid-containing drugs and there is not sufficient evidence available from relevant randomised controlled trials to base a decision on whether or not to permit such drugs in palliative care in Norway. It is however likely that drugs containing cannabinoids can help to control certain symptoms in some patients.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Continuing Care
Analgesia and Pain Management
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
